IL117727A - Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them - Google Patents

Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them

Info

Publication number
IL117727A
IL117727A IL11772796A IL11772796A IL117727A IL 117727 A IL117727 A IL 117727A IL 11772796 A IL11772796 A IL 11772796A IL 11772796 A IL11772796 A IL 11772796A IL 117727 A IL117727 A IL 117727A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
hiv activity
synergistic combinations
synergistic
Prior art date
Application number
IL11772796A
Other languages
English (en)
Other versions
IL117727A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117727(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL117727A0 publication Critical patent/IL117727A0/xx
Publication of IL117727A publication Critical patent/IL117727A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
IL11772796A 1995-03-30 1996-03-29 Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them IL117727A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations

Publications (2)

Publication Number Publication Date
IL117727A0 IL117727A0 (en) 1996-07-23
IL117727A true IL117727A (en) 1999-11-30

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11772796A IL117727A (en) 1995-03-30 1996-03-29 Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them

Country Status (35)

Country Link
US (1) US6417191B1 (2)
EP (1) EP0817637B1 (2)
JP (1) JP2954357B2 (2)
KR (1) KR100542536B1 (2)
CN (1) CN1103593C (2)
AP (1) AP652A (2)
AT (1) ATE220551T1 (2)
AU (1) AU715213B2 (2)
BR (3) BR9607851B1 (2)
CA (1) CA2216634C (2)
CZ (1) CZ295940B6 (2)
DE (3) DE122005000029I1 (2)
DK (1) DK0817637T3 (2)
EA (1) EA000626B3 (2)
EE (1) EE04047B1 (2)
ES (1) ES2179193T3 (2)
FR (1) FR05C0022I2 (2)
GE (1) GEP20022647B (2)
HU (1) HU224010B1 (2)
IL (1) IL117727A (2)
LU (1) LU91171I2 (2)
MX (1) MX9707316A (2)
MY (1) MY115461A (2)
NL (1) NL300195I2 (2)
NO (2) NO313787B1 (2)
NZ (1) NZ306419A (2)
OA (1) OA10616A (2)
PL (1) PL187085B1 (2)
PT (1) PT817637E (2)
RO (1) RO117995B1 (2)
SI (1) SI0817637T1 (2)
SK (1) SK283825B6 (2)
TR (1) TR199701074T1 (2)
UA (1) UA60293C2 (2)
WO (1) WO1996030025A1 (2)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU727983B2 (en) * 1996-06-25 2001-01-04 Glaxo Group Limited Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatment of HIV
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
AR012702A1 (es) * 1997-05-17 2000-11-08 Glaxo Group Ltd Combinacion de (-)-(1s,4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]- 2-ciclopenteno-1-metanol y un inhibidor dee transcriptasa reversa no nucleosidouna formulacion farmaceutica que comprende la combinacion, su uso medico en terapia para tratar la infeccion de vih, y un empaque para el paciente
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
WO1999060988A2 (en) * 1998-05-29 1999-12-02 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
AR040242A1 (es) * 2002-06-04 2005-03-23 Glaxo Group Ltd Composiciones farmaceuticas
KR100860136B1 (ko) 2003-01-14 2008-09-25 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
BRPI0408704A (pt) 2003-03-24 2006-03-07 Hoffmann La Roche benzil-piridazinonas como inibidores de transcriptase reversa
WO2005040816A1 (en) 2003-10-24 2005-05-06 Immunaid Pty Ltd Method of therapy
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
WO2007045573A1 (en) 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag Phenyl-acetamide nnrt inhibitors
JP5415957B2 (ja) 2006-12-13 2014-02-12 エフ．ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としての２−（ピペリジン−４−イル）−４−フェノキシ−又はフェニルアミノ−ピリミジン誘導体
PL2120878T3 (pl) * 2007-02-09 2015-01-30 Alphapharm Pty Ltd Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych
HUE026456T2 (en) 2009-05-27 2016-05-30 Biotempus Ltd Methods of treating diseases
LT2932970T (lt) 2010-01-27 2018-06-25 Viiv Healthcare Company Antivirusinė terapija
CA2918707A1 (en) 2013-08-29 2015-03-05 Teva Pharmaceuticals Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
EP3129009A1 (en) 2014-04-08 2017-02-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
AU2015303835B2 (en) 2014-08-12 2020-04-09 Monash University Lymph directing prodrugs
US11738087B2 (en) 2015-09-08 2023-08-29 Monash University Lymph directing prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
EP4306524A3 (en) * 2017-08-29 2024-09-11 PureTech LYT, Inc. Lymphatic system-directing lipid prodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
IL295362A (en) 2020-02-05 2022-10-01 Puretech Lyt Inc Lipid drug inhibitors of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
SK279262B6 (sk) 1991-05-16 1998-08-05 Glaxo Group Limited Protivírusová zmes, farmaceutický prostriedok s je
AU4079593A (en) * 1992-05-13 1993-12-13 Wellcome Foundation Limited, The Therapeutic combinations
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
DE69718168T2 (de) 1996-06-25 2003-10-23 Glaxo Group Ltd., Greenford Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
AU727983B2 (en) 1996-06-25 2001-01-04 Glaxo Group Limited Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatment of HIV
DE10226522A1 (de) 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
CA2216634C (en) 2004-07-20
SI0817637T1 (en) 2002-10-31
IL117727A0 (en) 1996-07-23
BRPI9607851B8 (pt) 2019-11-05
NO974510D0 (no) 1997-09-29
ATE220551T1 (de) 2002-08-15
BRPI9612992B1 (pt) 2020-08-04
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
FR05C0022I2 (2) 2005-10-21
OA10616A (en) 2001-03-15
KR19980703420A (ko) 1998-11-05
CZ295940B6 (cs) 2005-12-14
CN1185110A (zh) 1998-06-17
EA199700203A1 (ru) 1998-02-26
DK0817637T3 (da) 2002-11-11
CZ309097A3 (cs) 1998-05-13
EE04047B1 (et) 2003-06-16
EP0817637A1 (en) 1998-01-14
DE122005000029I1 (de) 2005-10-06
HK1009401A1 (en) 1999-09-10
EA000626B1 (ru) 1999-12-29
AU715213B2 (en) 2000-01-20
NO2005014I2 (no) 2008-02-11
BR9607851B1 (pt) 2009-01-13
DE122005000029I2 (de) 2006-04-27
NO2005014I1 (no) 2005-06-06
MX9707316A (es) 1997-11-29
PL187085B1 (pl) 2004-05-31
WO1996030025A1 (en) 1996-10-03
UA60293C2 (uk) 2003-10-15
JP2954357B2 (ja) 1999-09-27
DE69622386D1 (de) 2002-08-22
HUP9801571A2 (hu) 1999-01-28
PL322532A1 (en) 1998-02-02
EA000626B3 (ru) 2016-04-29
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
CN1103593C (zh) 2003-03-26
NO313787B1 (no) 2002-12-02
GEP20022647B (en) 2002-03-25
NL300195I2 (nl) 2005-11-01
ES2179193T3 (es) 2003-01-16
SK129597A3 (en) 1998-07-08
BR9607851A (pt) 1998-07-21
AP652A (en) 1998-06-19
RO117995B1 (ro) 2002-12-30
FR05C0022I1 (2) 2005-06-10
LU91171I9 (2) 2018-12-28
LU91171I2 (fr) 2005-07-04
KR100542536B1 (ko) 2006-03-23
HUP9801571A3 (en) 2001-04-28
US6417191B1 (en) 2002-07-09
EP0817637B1 (en) 2002-07-17
MY115461A (en) 2003-06-30
DE69622386T2 (de) 2003-02-13
CA2216634A1 (en) 1996-10-03
NO974510L (no) 1997-09-29
SK283825B6 (sk) 2004-02-03
AU5497296A (en) 1996-10-16
HU224010B1 (hu) 2005-04-28
AP9701089A0 (en) 1997-10-31
JPH10511682A (ja) 1998-11-10
EE9700240A (et) 1998-04-15

Similar Documents

Publication Publication Date Title
IL117727A0 (en) Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL114626A0 (en) 6-membered nitrogen-containing heteroaryl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
HU9502918D0 (en) Pharmaceutical composition of antihypertriglyceridemic activity
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL107653A0 (en) N,n-disubstituted arylcycloalkylamines their preparation and pharmaceutical compositions containing them
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
IL105135A (en) Carbapenems their preparation their use and pharmaceutical compositions containing them
IL116190A (en) Eleutherobin, analogs thereof and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
IL113415A (en) Dihydrodibenziso-quinolinediones their preparation and pharmaceutical compositions containing them
IL106290A0 (en) Enzyme inhibitors,their preparation and pharmaceutical compositions containing them
IL111216A0 (en) Heteroarylpiperidines, their preparation and pharmaceutical compositions containing them
IL115982A (en) Cyclolignan derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HK Corrigendum

Free format text: JOURNAL NO. 4/96 P. 1004, PATENT APPLICATION NO. 117727, ADD FURTHER PRIORITY 9506489.5 30.03.1995GB

FF Patent granted
KB Patent renewed
KB Patent renewed
EXTF Application for patent extension filed
KB Patent renewed
KB Patent renewed
EXP Patent expired